Advertisement

Index by author

February 01, 2001; Volume 296,Issue 2

  1. Ebetino, Frank H.

    1. Structure-Activity Relationships for Inhibition of Farnesyl Diphosphate Synthase in Vitro and Inhibition of Bone Resorption in Vivo by Nitrogen-Containing Bisphosphonates
      James E. Dunford, Keith Thompson, Fraser P. Coxon, Steven P. Luckman, Frederick M. Hahn, C. Dale Poulter, Frank H. Ebetino and Michael J. Rogers
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 235-242;

  2. Eisenberg, Paul R.

    1. A Novel Synthetic Inhibitor of Factor Xa Decreases Early Reocclusion and Improves 24-h Patency after Coronary Fibrinolysis in Dogs
      Dana R. Abendschein, Pamela K. Baum, Peter Verhallen, Paul R. Eisenberg, Mark E. Sullivan and David R. Light
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 567-572;

  3. Elmquist, William F.

    1. Pluronic P85 Enhances the Delivery of Digoxin to the Brain: In Vitro and in Vivo Studies
      Elena V. Batrakova, Donald W. Miller, Shu Li, Valery Yu Alakhov, Alexander V. Kabanov and William F. Elmquist
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 551-557;

  4. Elsby, Robert

    1. Assessment of the Effects of Metabolism on the Estrogenic Activity of Xenoestrogens: A Two-Stage Approach Coupling Human Liver Microsomes and a Yeast Estrogenicity Assay
      Robert Elsby, James L. Maggs, John Ashby, David Paton, John P. Sumpter and B. Kevin Park
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 329-337;

  5. Emerich, Dwaine F.

    1. Bradykinin Modulation of Tumor Vasculature: I. Activation of B2 Receptors Increases Delivery of Chemotherapeutic Agents into Solid Peripheral Tumors, Enhancing Their Efficacy
      Dwaine F. Emerich, Pamela Snodgrass, Reginald L. Dean, Denise Lafreniere, Mary Agostino, Tania Wiens, Hua Xiong, Brant Hasler, Joanne Marsh, Melissa Pink, Byong Su Kim and Raymond T. Bartus
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 623-631;
    2. Bradykinin Modulation of Tumor Vasculature: II. Activation of Nitric Oxide and Phospholipase A2/Prostaglandin Signaling Pathways Synergistically Modifies Vascular Physiology and Morphology to Enhance Delivery of Chemotherapeutic Agents to Tumors
      Dwaine F. Emerich, Reginald L. Dean, Pamela Snodgrass, Denise Lafreniere, Mary Agostino, Tania Wiens, Hua Xiong, Brant Hasler, Joanne Marsh, Melissa Pink, Byong Su Kim, Brigido Perdomo and Raymond T. Bartus
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 632-641;

  6. Erhardt, J. A.

    1. SB 239063, a Second-Generation p38 Mitogen-Activated Protein Kinase Inhibitor, Reduces Brain Injury and Neurological Deficits in Cerebral Focal Ischemia
      F. C. Barone, E. A. Irving, A. M. Ray, J. C. Lee, S. Kassis, S. Kumar, A. M. Badger, R. F. White, M. J. McVey, J. J. Legos, J. A. Erhardt, A. H. Nelson, E. H. Ohlstein, A. J. Hunter, K. Ward, B. R. Smith, J. L. Adams and A. A. Parsons
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 312-321;

  7. Eshleman, Amy J.

    1. Drug Interactions with the Dopamine Transporter in Cryopreserved Human Caudate
      Amy J. Eshleman, Katherine Wolfrum, Deborah C. Mash, Kevin Christensen and Aaron Janowsky
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 442-449;

  8. Ethier, D.

    1. Etoricoxib (MK-0663): Preclinical Profile and Comparison with Other Agents That Selectively Inhibit Cyclooxygenase-2
      D. Riendeau, M. D. Percival, C. Brideau, S. Charleson, D. Dubé, D. Ethier, J.-P. Falgueyret, R. W. Friesen, R. Gordon, G. Greig, J. Guay, J. Mancini, M. Ouellet, E. Wong, L. Xu, S. Boyce, D. Visco, Y. Girard, P. Prasit, R. Zamboni, I. W. Rodger, M. Gresser, A. W. Ford-Hutchinson, R. N. Young and C.-C. Chan
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 558-566;

  9. Falgueyret, J.-P.

    1. Etoricoxib (MK-0663): Preclinical Profile and Comparison with Other Agents That Selectively Inhibit Cyclooxygenase-2
      D. Riendeau, M. D. Percival, C. Brideau, S. Charleson, D. Dubé, D. Ethier, J.-P. Falgueyret, R. W. Friesen, R. Gordon, G. Greig, J. Guay, J. Mancini, M. Ouellet, E. Wong, L. Xu, S. Boyce, D. Visco, Y. Girard, P. Prasit, R. Zamboni, I. W. Rodger, M. Gresser, A. W. Ford-Hutchinson, R. N. Young and C.-C. Chan
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 558-566;

  10. Ferreira, Manuel

    1. Evidence of a Functional α7-Neuronal Nicotinic Receptor Subtype Located on Motoneurons of the Dorsal Motor Nucleus of the Vagus
      Manuel Ferreira, Steven N. Ebert, David C. Perry, Robert P. Yasuda, Chandra M. Baker, Martha I. Dávila-García, Kenneth J. Kellar and Richard A. Gillis
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 260-269;
« Previous (Pages : 3 4 5 6 7 8 9 10 11 12 ... 32) Next »
Back to top

In this issue

Advertisement